Palisade Bio, Inc. (PALI) Financials

$1.76

south_east
-$0.07 (-3.83%)
Day's range
$1.61
Day's range
$1.9

PALI Income statement / Annual

Last year (2023), Palisade Bio, Inc.'s total revenue was $250,000.00, and the percentage change from the previous year is not available. In 2023, Palisade Bio, Inc.'s net income was -$12.30 M. See Palisade Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $250,000.00 $0.00 $0.00 $13,520.00 $15,394.00 $260,000.00 $260,000.00 $16,246.00 $10,417.00 $18,833.00
Cost of Revenue $0.00 $167,000.00 $168,000.00 $146,000.00 $0.00 -$990,000.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $250,000.00 -$167,000.00 -$168,000.00 -$132,480.00 $15,394.00 $1.25 M $260,000.00 $16,246.00 $10,417.00 $18,833.00
Gross Profit Ratio 1 0 0 -9.8 1 4.81 1 1 1 1
Research and Development Expenses $6.89 M $6.55 M $32.55 M $3.10 M $4.06 M $3.96 M $8.00 M $12.84 M $12.64 M $8.13 M
General & Administrative Expenses $6.20 M $8.76 M $9.31 M $6.20 M $7.27 M $3.57 M $5.47 M $7.50 M $6.53 M $8.97 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 -$2.83 M $807,462.00 -$289,208.00 -$495,508.00 -$345,460.00 $0.00
Selling, General & Administrative Expenses $6.20 M $8.76 M $9.31 M $6.20 M $4.44 M $4.37 M $5.18 M $7.00 M $6.18 M $8.97 M
Other Expenses $225,000.00 $158,000.00 -$1.74 M $13,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $348,630.00
Operating Expenses $13.32 M $15.31 M $41.85 M $9.30 M $8.50 M $8.33 M $13.19 M $19.85 M $18.82 M $17.45 M
Cost And Expenses $13.32 M $15.31 M $41.85 M $9.30 M $8.65 M $8.52 M $13.48 M $20.18 M $19.17 M $17.45 M
Interest Income $0.00 $13,000.00 $3.08 M $33,532.00 $67,731.00 $78,780.00 $70,269.00 $58,835.00 $69,549.00 $67,651.00
Interest Expense $15,000.00 $13,000.00 $2.40 M $235,000.00 $8,920.00 $7,698.00 $159,066.00 $1.14 M $1.82 M $1.62 M
Depreciation & Amortization $4,000.00 $167,000.00 $168,000.00 $146,000.00 $143,859.00 $185,803.00 $289,208.00 $337,508.00 $345,460.00 $348,630.00
EBITDA -$12.28 M -$15.31 M -$24.05 M -$9.94 M -$8.20 M -$4.73 M -$15.22 M -$19.60 M -$18.74 M -$20.66 M
EBITDA Ratio -49.12 0 0 -748.67 -551.37 -31.05 -49.71 -1220.57 -1805.8 -1096.98
Operating Income Ratio -52.28 0 0 -687.65 -560.72 -31.77 -50.83 -1241.34 -1838.97 -925.81
Total Other Income/Expenses Net $770,000.00 $1.46 M $15.24 M -$1.03 M $280,043.00 -$1.86 M -$2.45 M -$907,768.00 -$1.75 M -$5.19 M
Income Before Tax -$12.30 M -$14.26 M -$26.62 M -$10.32 M -$8.35 M -$4.92 M -$15.67 M -$21.07 M -$20.90 M -$22.63 M
Income Before Tax Ratio -49.2 0 0 -763.46 -542.53 -18.94 -60.25 -1297.22 -2006.71 -1201.55
Income Tax Expense $0.00 -$1.46 M $655,000.00 $248,000.00 $288,963.00 $3.34 M -$2.20 M $703,529.00 $68,833.00 -$3.57 M
Net Income -$12.30 M -$12.80 M -$27.27 M -$10.57 M -$8.35 M -$4.92 M -$15.67 M -$21.07 M -$20.90 M -$22.63 M
Net Income Ratio -49.2 0 0 -781.8 -542.53 -18.94 -60.25 -1297.22 -2006.71 -1201.55
EPS -27.01 -218.14 -2608.92 -190.5 -221.64 -270.35 -1073.82 -1891.63 -17943.85 -3377.93
EPS Diluted -27.01 -218.09 -2187.98 -190.5 -221.64 -270.35 -1070.08 -1891.63 -17943.85 -3377.93
Weighted Average Shares Out $456,014.00 $58,673.00 $10,453.00 $55,487.00 $37,681.00 $18,216.00 $14,589.00 $11,141.00 $7,061.00 $6,699.00
Weighted Average Shares Out Diluted $456,014.00 $58,687.00 $12,464.00 $55,487.00 $37,681.00 $18,216.00 $14,640.00 $11,141.00 $7,061.00 $6,699.00
Link